Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models

Antibody‐based photodynamic therapy, or photoimmunotherapy (PIT), is a novel, targeted cancer therapy, which can serve as both a diagnostic and a therapeutic agent. The primary objective of this study was to evaluate the capacity of panitumumab‐IRDye700DX (Pan‐IR700) to eliminate microscopic tumor r...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Lindsay S., de Boer, Esther, Warram, Jason M., Tucker, Matthew D., Carroll, William R., Korb, Melissa L., Brandwein‐Gensler, Margaret S., van Dam, Gooitzen M., Rosenthal, Eben L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867660/
https://www.ncbi.nlm.nih.gov/pubmed/27167827
http://dx.doi.org/10.1002/cam4.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867660/
https://www.ncbi.nlm.nih.gov/pubmed/27167827
http://dx.doi.org/10.1002/cam4.752

Ejemplares similares